| 000 | 01629 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516001618.0 | ||
| 264 | 0 | _c20120905 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1873-2496 | ||
| 024 | 7 |
_a10.1016/j.urolonc.2010.02.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStaehler, Michael | |
| 245 | 0 | 0 |
_aFeasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer. _h[electronic resource] |
| 260 |
_bUrologic oncology _c |
||
| 300 |
_a290-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose Fractionation, Radiation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 |
_aRadiotherapy _xmethods |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHaseke, Nicolas | |
| 700 | 1 | _aStadler, Thomas | |
| 700 | 1 | _aNuhn, Philipp | |
| 700 | 1 | _aRoosen, Alexander | |
| 700 | 1 | _aStief, Christian G | |
| 700 | 1 | _aWilkowski, Ralf | |
| 773 | 0 |
_tUrologic oncology _gvol. 30 _gno. 3 _gp. 290-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2010.02.006 _zAvailable from publisher's website |
| 999 |
_c20146575 _d20146575 |
||